Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Institute of Biomedical Research and Innovation , Kobe, Japan

Survival: 9.5 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: Japan
City/State/Province: Kobe
Hospital: Institute of Biomedical Research and Innovation
Journal: Link
Date: 6/2015

This phase 2 study involved 28 advanced non‑squamous non‑small cell lung cancer patients who had not received prior chemotherapy. The median patient age was 75 years and 75% were male.

Patients received chemotherapy with pemetrexed.

The most severe toxicities were of grade 4 and included leukopenia, neutropenia, and shortness of breath. Grade 3 fatigue and nausea were also reported.

The median overall survival was 9.5 months.

Some of the authors have received minor support from Eli Lilly.

Correspondence: Dr. Akito Hata; email:

E-mail to a Friend Email Physician More Information